Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy With Immune Checkpoint Inhibitors

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
doi 10.29021/spdv.76.1.868
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portuguese Society of Dermatology and Venereology

Related search

Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure–Response Relationships

Clinical Pharmacokinetics
Pharmacology
2019English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Immune Checkpoint Inhibitors Therapy in Older Patients (≥ 70 Years) With Metastatic Melanoma: A Multicentre Study

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Is There a Role for Immune Checkpoint Blockade in Metastatic Uveal Melanoma?

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy